CoChat
Sign Up
Cited by 501Antibiotic Use and ResistanceAntibiotic Resistance in BacteriaPharmaceutical Economics and Policy

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000–15: an analysis of pharmaceutical sales data

Klein, Eili Y, Milkowska-Shibata, Maja, Tseng, Katie K, Sharland, Mike, Gandra, Sumanth, Pulcini, Céline, Laxminarayan, Ramanan·2021·The Lancet Infectious Diseases
DOI 10.1016/s1473-3099(20)30332-7
Open this paper in CoChat — free account

Abstract

Background The WHO Access, Watch, and Reserve (AWaRe) antibiotic classification framework aims to balance appropriate access to antibiotics and stewardship. We aimed to identify how patterns of antibiotic consumption in each of the AWaRe categories changed across countries over 15 years. Methods Antibiotic consumption was classified into Access, Watch, and Reserve categories for 76 countries between 2000, and 2015, using quarterly national sample survey data obtained from IQVIA. We measured the proportion of antibiotic use in each category, and calculated the ratio of Access antibiotics to Watch antibiotics (access-to-watch index), for each country. Findings Between 2000, and 2015, global per-capita consumption of Watch antibiotics increased by 90·9% (from 3·3 to 6·3 defined daily doses per 1000 inhabitants per day [DIDs]) compared with an increase of 26·2% (from 8·4 to 10·6 DIDs) in Access antibiotics. The increase in Watch antibiotic consumption was greater in low-income and middle-income countries (LMICs; 165·0%; from 2·0 to 5·3 DIDs) than in high-income countries (HICs; 27·9%; from 6·1 to 7·8 DIDs). The access-to-watch index decreased by 38·5% over the study period globally (from 2·6 to 1·6); 46·7% decrease in LMICs (from 3·0 to 1·6) and 16·7% decrease in HICs (from 1·8 to 1·5), and 37 (90%) of 41 LMICs had a decrease in their relative access-to-watch consumption. The proportion of countries in which Access antibiotics represented at least 60% of their total antibiotic consumption (the WHO national-level target) decreased from 50 (76%) of 66 countries in 2000, to 42 (55%) of 76 countries in 2015. Interpretation Rapid increases in Watch antibiotic consumption, particularly in LMICs, reflect challenges in antibiotic stewardship. Without policy changes, the WHO national-level target of at least 60% of total antibiotic consumption being in the Access category by 2023, will be difficult to achieve. The AWaRe framework is an important measure of the effort to combat antimicrobial resistance and to ensure equal access to effective antibiotics between countries. Funding US Centers for Disease Control and Prevention.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(20)30332-7

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

Sorted by citations

See all 501

Related

See all

Metadata

Authors
Klein, E. Y., Milkowska-Shibata, M., Tseng, K. K., Sharland, M., Gandra, S., Pulcini, C., & Laxminarayan, R.
Affiliations
  • Center for Disease Dynamics, Economics & Policy (US)
  • St George's, University of London (GB)
  • Washington University in St. Louis (US)
Corresponding author
Klein, Eili Y
ORCID
Venue
The Lancet Infectious Diseases
Publisher
Elsevier BV
Published
2021-01
Volume
21
Issue
1
Pages
107-115
ISSN
1473-3099 (ISSN-L)
DOI
10.1016/s1473-3099(20)30332-7
OpenAlex
W3044776476
Cited by
500
References
26
Citations by year
2026: 61 · 2025: 95 · 2024: 110 · 2023: 94 · 2022: 78 · 2021: 58
FWCI
34.82
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • The Lancet Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • St George's Online Research Archive (St George's University of London) (acceptedVersion)
  • HAL (submittedVersion)
Funders
Centers for Disease Control and Prevention
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
  • Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
Keywords
antibiotic use, AWaRe classification, antibiotic access, antibiotic stewardship, pharmaceutical sales data, Watch antibiotics, low- and middle-income countries, high-income countries, defined daily doses, antimicrobial resistance, cross-national comparison
MeSH terms
Antimicrobial Stewardship, Anti-Bacterial Agents, Commerce, Developing Countries, Drug Utilization, Pharmaceutical Preparations, Forecasting, Humans, World Health Organization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review